Roche Gets Reprieve On Avastin For Breast Cancer With Delay At FDA

FDA extends user fee date in lieu of reaching decision on whether or not to pull the breast cancer approval for bevacizumab.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet